HK1048995B - 抑制血管生成的雜環化合物 - Google Patents

抑制血管生成的雜環化合物

Info

Publication number
HK1048995B
HK1048995B HK03101165.4A HK03101165A HK1048995B HK 1048995 B HK1048995 B HK 1048995B HK 03101165 A HK03101165 A HK 03101165A HK 1048995 B HK1048995 B HK 1048995B
Authority
HK
Hong Kong
Prior art keywords
heterocyclic compounds
inhibiting angiogenesis
compounds inhibiting
angiogenesis
heterocyclic
Prior art date
Application number
HK03101165.4A
Other languages
English (en)
Other versions
HK1048995A1 (en
Inventor
N‧馬克
G‧阿伯拉斯
A‧泰格德斯
A‧傑尼
F‧蒂瑪
Original Assignee
伊瓦克斯藥品研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 伊瓦克斯藥品研究院有限公司 filed Critical 伊瓦克斯藥品研究院有限公司
Publication of HK1048995A1 publication Critical patent/HK1048995A1/xx
Publication of HK1048995B publication Critical patent/HK1048995B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
HK03101165.4A 1999-08-02 2003-02-18 抑制血管生成的雜環化合物 HK1048995B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902628A HUP9902628A3 (en) 1999-08-02 1999-08-02 Angiogenesis inhibiting borrelidin derivatives, their use and pharmaceutical compositions containing them
PCT/HU2000/000088 WO2001009113A2 (en) 1999-08-02 2000-08-02 Heterocyclic compounds inhibiting angiogenesis

Publications (2)

Publication Number Publication Date
HK1048995A1 HK1048995A1 (en) 2003-04-25
HK1048995B true HK1048995B (zh) 2006-07-21

Family

ID=89998954

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101165.4A HK1048995B (zh) 1999-08-02 2003-02-18 抑制血管生成的雜環化合物

Country Status (32)

Country Link
US (1) US6815465B1 (zh)
EP (1) EP1206462B1 (zh)
JP (1) JP2003506366A (zh)
KR (1) KR20020068495A (zh)
CN (1) CN1243746C (zh)
AP (1) AP1383A (zh)
AT (1) ATE241611T1 (zh)
AU (1) AU772206B2 (zh)
BG (1) BG106373A (zh)
BR (1) BR0012968A (zh)
CA (1) CA2378176A1 (zh)
CZ (1) CZ2002405A3 (zh)
DE (1) DE60003045T2 (zh)
DK (1) DK1206462T3 (zh)
ES (1) ES2200900T3 (zh)
HK (1) HK1048995B (zh)
HR (1) HRP20020103B1 (zh)
HU (1) HUP9902628A3 (zh)
IL (1) IL147904A (zh)
IS (1) IS2137B (zh)
MX (1) MXPA02001117A (zh)
NO (1) NO20020485L (zh)
NZ (1) NZ517422A (zh)
OA (1) OA12004A (zh)
PL (1) PL354281A1 (zh)
PT (1) PT1206462E (zh)
RU (1) RU2247723C2 (zh)
SK (1) SK1822002A3 (zh)
UA (1) UA74341C2 (zh)
WO (1) WO2001009113A2 (zh)
YU (1) YU7302A (zh)
ZA (1) ZA200200838B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
ATE452896T1 (de) 2002-03-12 2010-01-15 Bristol Myers Squibb Co C3-cyanoepothilonderivate
GB0230217D0 (en) 2002-12-27 2003-02-05 Biotica Tech Ltd Borrelidin-producing polyketide synthase and its uses
US8440217B1 (en) 2005-06-15 2013-05-14 Mawaheb M. EL-Naggar Method and system with contact lens product for treating and preventing adverse eye conditions
GB0609981D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
GB0713563D0 (en) * 2007-07-13 2007-08-22 Biotica Tech Ltd Methods of screening for anti-angiogenic compounds
PL2197280T3 (pl) * 2007-08-27 2013-11-29 Basf Se Związki pirazolowe do zwalczania szkodników będących bezkręgowcami
DE102008014077A1 (de) 2008-03-13 2009-09-17 Discovery Partner International Gmbh Borrelidin-Derivate
WO2009141786A2 (en) * 2008-05-21 2009-11-26 Piramal Life Sciences Limited Anti-inflammatory compounds
ES2720781T3 (es) 2014-12-15 2019-07-24 Borealis Ag Uso de una composición de polipropileno

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08173176A (ja) * 1994-12-22 1996-07-09 Mercian Corp 血管新生阻害剤
JP3786461B2 (ja) * 1996-02-22 2006-06-14 メルシャン株式会社 新生理活性物質

Also Published As

Publication number Publication date
AU772206B2 (en) 2004-04-22
ATE241611T1 (de) 2003-06-15
DK1206462T3 (da) 2003-09-29
ZA200200838B (en) 2003-08-27
HRP20020103A2 (en) 2004-02-29
AP2002002413A0 (en) 2002-03-31
IS2137B (is) 2006-08-14
US6815465B1 (en) 2004-11-09
BG106373A (en) 2002-09-30
OA12004A (en) 2006-04-18
NZ517422A (en) 2005-02-25
ES2200900T3 (es) 2004-03-16
RU2247723C2 (ru) 2005-03-10
EP1206462A2 (en) 2002-05-22
IS6258A (is) 2002-02-01
AP1383A (en) 2005-04-05
KR20020068495A (ko) 2002-08-27
NO20020485D0 (no) 2002-01-30
DE60003045D1 (de) 2003-07-03
WO2001009113A2 (en) 2001-02-08
SK1822002A3 (en) 2002-08-06
EP1206462B1 (en) 2003-05-28
IL147904A (en) 2005-09-25
HK1048995A1 (en) 2003-04-25
PT1206462E (pt) 2003-10-31
PL354281A1 (en) 2003-12-29
AU6309000A (en) 2001-02-19
DE60003045T2 (de) 2004-04-01
BR0012968A (pt) 2002-05-14
HU9902628D0 (en) 1999-10-28
JP2003506366A (ja) 2003-02-18
CN1243746C (zh) 2006-03-01
WO2001009113A3 (en) 2001-06-14
HUP9902628A2 (hu) 2001-05-28
YU7302A (sh) 2004-09-03
NO20020485L (no) 2002-03-21
CZ2002405A3 (cs) 2002-07-17
CA2378176A1 (en) 2001-02-08
UA74341C2 (uk) 2005-12-15
HRP20020103B1 (en) 2005-06-30
CN1372556A (zh) 2002-10-02
MXPA02001117A (es) 2003-08-20
HUP9902628A3 (en) 2001-07-30
IL147904A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
GB9929973D0 (en) Heterocyclic compounds
HUP0203375A3 (en) Substituted oxoazaheterocyclyl compounds
GB9800575D0 (en) Heterocyclic compounds
GB2357761B (en) Compounds
EP1242072A4 (en) ANTIPSYCHOTIC HETEROCYCLIC COMPOUNDS
EP1146871A4 (en) HETEROCYCLIC ANTIDEPRESSANT COMPOUNDS
HK1048995A1 (en) Heterocyclic compounds inhibiting angiogenesis
AU5884101A (en) Heterocyclic compounds
GB9902399D0 (en) Compounds
GB9929037D0 (en) Heterocyclic derivatives
SI1206462T1 (en) Heterocyclic compounds inhibiting angiogenesis
GB9916216D0 (en) Heterocyclic compounds
GB9915510D0 (en) Heterocyclic compounds
GB9916213D0 (en) Heterocyclic compounds
GB9916218D0 (en) Heterocyclic compounds
GB9914173D0 (en) New heterocyclic compounds
GB9812403D0 (en) Heterocyclic compounds
GB9812408D0 (en) Heterocyclic compounds
GB9800557D0 (en) Heterocyclic compounds
GB9800571D0 (en) Heterocyclic compounds
GB9800564D0 (en) Heterocyclic compounds
GB9800572D0 (en) Heterocyclic compounds
GB9800567D0 (en) Heterocyclic compounds
GB9903337D0 (en) Heterocyclic derivatives
GB9929038D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090802